Top compounds associated with response to MYO1F


Feature Type Standardized
Nominal ANOVA
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.44 2e-34
mRNA linifanib GDSC1000 pan-cancer AAC 0.42 3e-27
mRNA AC220 GDSC1000 pan-cancer AAC 0.35 5e-20
mRNA ATRA CTRPv2 pan-cancer AAC 0.34 6e-20
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.29 4e-14
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.27 5e-14
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.25 9e-14
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.28 1e-13
mRNA ATRA GDSC1000 pan-cancer AAC 0.28 3e-13
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.28 2e-12
Download CSV